Home › NDC Lookup › RxCUI directory › RxCUI 2612098

Deucravacitinib 6 MG Oral Tablet [Sotyktu] — RxCUI 2612098

RxNorm drug concept · Semantic branded drug
RxCUI 2612098 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2612098
Official nameDeucravacitinib 6 MG Oral Tablet [Sotyktu]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSotyktu 6 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)4,009 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Deucravacitinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sotyktu works by quieting down a specific part of the immune system — an enzyme called TYK2 — that drives the inflammation behind psoriatic skin flares and joint pain. For moderate...
  • What exactly is Sotyktu supposed to do for my psoriasis or psoriatic arthritis?
  • Yes — a couple of important things. Your doctor needs to test you for tuberculosis (TB) before you start, because Sotyktu can reactivate a latent (hidden, inactive) TB infection. Y...
  • Do I have to do anything before I can start taking Sotyktu?
📖 Read our full Deucravacitinib guide →

🕸️ Concept Web — How Deucravacitinib 6 MG Oral Tablet [Sotyktu] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Deucravacitinib 6 MG Oral Tablet [Sotyktu] RxCUI 2612098

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Deucravacitinib 2612087
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sotyktu 2612093
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Deucravacitinib Oral Tablet 2612091
    • Deucravacitinib Oral Product 2612089
    • Deucravacitinib Pill 2612090
    • Deucravacitinib Oral Tablet [Sotyktu] 2612097
    • Sotyktu Oral Product 2612095
    • Sotyktu Pill 2612096
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Deucravacitinib 6 MG Oral Tablet SCD · 2612092
  • Deucravacitinib 6 MG SCDC · 2612088
  • Deucravacitinib Oral Tablet SCDF · 2612091
  • Deucravacitinib Oral Product SCDG · 2612089
  • Deucravacitinib Pill SCDG · 2612090

Brand-Name Concepts

  • Deucravacitinib 6 MG [Sotyktu] SBDC · 2612094
  • Deucravacitinib Oral Tablet [Sotyktu] SBDF · 2612097
  • Sotyktu Oral Product SBDG · 2612095
  • Sotyktu Pill SBDG · 2612096
  • Sotyktu BN · 2612093

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2612098 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00003-0895-11 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0895-11) SOTYKTU E.R. Squibb & Sons, L.L.C. 2022-09-09
00003-0895-91 30 TABLET, FILM COATED in 1 BLISTER PACK (0003-0895-91) SOTYKTU E.R. Squibb & Sons, L.L.C. 2022-09-09
Observed labelers: E.R. Squibb & Sons, L.L.C. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.